HCR Wealth Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$208K Buy
+2,265
New +$198K 0.02% 254
2026
Q1
Sell
-2,605
Closed -$206K 245
2025
Q4
$206K Sell
2,605
-200
-7% -$15.7K 0.02% 240
2025
Q3
$220K Buy
2,805
+194
+7% +$16.5K 0.02% 223
2025
Q2
$237K Hold
2,611
0.03% 210
2025
Q1
$245K Sell
2,611
-125
-5% -$11.2K 0.03% 201
2024
Q4
$249K Buy
2,736
+6
+0.2% +$573 0.03% 197
2024
Q3
$283K Hold
2,730
0.04% 184
2024
Q2
$265K Hold
2,730
0.04% 183
2024
Q1
$246K Hold
2,730
0.04% 190
2023
Q4
$218K Buy
+2,730
New +$205K 0.03% 188

Other funds holding CL

HCR Wealth Advisors's CL Position: Q2 2026 in Review

HCR Wealth Advisors opened a new position in Colgate-Palmolive (CL) in Q2 2026: 2,265 shares worth $208K. The stake represents 0.02% of the portfolio and ranks #254 among its holdings. This is a return to the name: HCR Wealth Advisors previously reported a position in CL as recently as Q4 2025.

HCR Wealth Advisors first reported a position in CL in Q4 2023 and has held it in 10 quarters since. The position peaked at $283K in Q3 2024. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • HCR Wealth Advisors held 2,265 shares of Colgate-Palmolive worth $208K as of Q2 2026.
  • Colgate-Palmolive was a new HCR Wealth Advisors position in Q2 2026.
  • Colgate-Palmolive made up 0.02% of HCR Wealth Advisors's portfolio in Q2 2026, its #254 holding.
  • HCR Wealth Advisors first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 10 quarters since.
  • HCR Wealth Advisors's Colgate-Palmolive position peaked at $283K in Q3 2024.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on HCR Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.